Feedback
TACI-Associated Common Variable Immunodeficiency (TNFRSF13B) Sequencing
2007569
Ordering Recommendation

Use to identify TNFRSF13B variants in individuals with clinical phenotype for common variable immunodeficiency and symptomatic selective IgA deficiency (IgAD).

Mnemonic
TACI FGS
Methodology
Polymerase Chain Reaction/Sequencing
Performed
Varies
Reported
14-21 days
New York DOH Approval Status
Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Lavender (EDTA), pink (K2 EDTA), or yellow (ACD Solution A or B). 
Specimen Preparation
Transport 3 mL whole blood. (Min: 1 mL) 
Storage/Transport Temperature
Refrigerated. 
Unacceptable Conditions
 
Remarks
 
Stability
Ambient: 72 hours; Refrigerated: 1 week; Frozen: Unacceptable 
Reference Interval
By report
Interpretive Data


Note
CPT Code(s)
81479
Components
Component Test Code*Component Chart NameLOINC
2007570TACI-Assoc CVID (TNFRSF13B) Seq Specimen
2007571TACI-Assoc CVID (TNFRSF13B) Seq Interp
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Antibody deficiency due to TACI defect
  • CVID/CVID2
  • Hypogammaglobulinemia due to TACI deficiency
  • IgA deficiency
  • IGAD2
  • Immunoglobulin A deficiency
  • Selective IgA deficiency-2
  • TNFRSF13B
  • Tumor necrosis factor receptor superfamily, member13B